Nektar Therapeutics (NKTR) Tax Provisions (2010 - 2026)
Nektar Therapeutics' (NKTR) quarterly Tax Provisions came in at $64000.0 in Q1 2026, up 23.08% year-on-year from $52000.0 in Q1 2025, and up 100.19% quarter-over-quarter from -$34.3 million in Q4 2025.
Nektar Therapeutics (NKTR) Tax Provisions (2010 - 2026) Analysis & Trends
Nektar Therapeutics' Tax Provisions history runs 17 years deep, the most recent figure standing at $64000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions rose 23.08% year-over-year to $64000.0 in Q1 2026; TTM through Mar 2026 was -$34.5 million, a 38.2% decrease from a year earlier, with the FY2025 full-year figure at -$34.5 million, down 37.76% from the prior year.
- Tax Provisions rose to $64000.0 in Q1 2026 per NKTR's latest filing, from -$34.3 million in the prior quarter.
- Across five years, Tax Provisions topped out at $126000.0 in Q1 2022 and bottomed at -$76.7 million in Q4 2022.
- The 5-year median for Tax Provisions is -$35000.0 (2024), against an average of -$8.0 million.
- Across the five-year window, Tax Provisions sank 1917850.0% in 2022 and soared 248.57% in 2025, its largest moves.
- Year by year, Tax Provisions stood at -$76.7 million in 2022, then jumped by 99.96% to -$29000.0 in 2023, then plunged by 86286.21% to -$25.1 million in 2024, then plunged by 36.98% to -$34.3 million in 2025, then surged by 100.19% to $64000.0 in 2026.
- Per Business Quant, the three latest NKTR Tax Provisions figures stand at $64000.0 (Q1 2026), -$34.3 million (Q4 2025), and -$33000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Nektar Therapeutics | 1.76 Bn | 1.19 Bn | 3.16 Mn | 64,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64,000.00 |
| Dec 31, 2025 | -34.32 Mn |
| Sep 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -188,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | -25.05 Mn |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Dec 31, 2023 | -29,000.00 |
| Sep 30, 2023 | -61,000.00 |
| Jun 30, 2023 | -47,000.00 |
| Mar 31, 2023 | -63,000.00 |
| Dec 31, 2022 | -76.72 Mn |
| Sep 30, 2022 | -155,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 126,000.00 |
| Dec 31, 2021 | -4,000.00 |
| Sep 30, 2021 | 112,000.00 |
| Jun 30, 2021 | 357,000.00 |